Can AI beat antibiotic resistance? Inside the future of drug discovery

As innovation accelerates, organizations are also looking for ways to communicate their role in tackling this challenge to highly engaged scientific audiences.

A recent Nature Technology Feature on Antibiotic Discovery/AI explores how artificial intelligence is transforming antibiotic discovery, helping researchers identify promising new compounds and rethink traditional development pathways.

Science has come a long way since Alexander Fleming discovered penicillin on a contaminated Petri dish.
For one thing, there are many more classes of antibiotics for doctors to choose from — and thanks to their overuse, plentiful pathogens that are immune to them. But the arms race between bacteria and biopharma continues and on the biopharma side, artificial intelligence is playing an ever-larger role.

Nature Technology Features provide a trusted editorial platform where complex scientific advances are explored in depth, reaching a global audience of researchers, clinicians and decision-makers.

They also offer organizations an opportunity to align their research with high-impact scientific storytelling, building visibility and credibility in a highly relevant context.